Sp1059
THE CLINICAL VALUE OF BIOMARKER-BASED APPROACHES FOR THE EVALUATION AND MANAGEMENT OF IRRITABLE BOWEL SYNDROME: PRICE VS. PRECISION
Date
May 9, 2023
Explore related products in the following collection:
Society: AGA
DDW attendees will have the opportunity to learn about recent developments in biomarker-discovery for FGID/DGBI and Neurogastroenterology. Speakers will cover investigational and evolving biomarkers, practical utilization of biomarkers, and updates on biomarkers that are further down the pipeline and may be available for broader use in clinical practice and clinical research. Discuss novel and investigational biomarkers in functional gastrointestinal disorders (disorders of gut-brain interaction) Recognize currently available biomarkers and their potential applications in clinical practice, their strengths, and their limitations. Review the path to biomarker discovery and their role in enhancing patient care, highlighting challenges and future goals.
DDW attendees will have the opportunity to learn about recent developments in biomarker-discovery for FGID/DGBI and Neurogastroenterology. Speakers will cover investigational and evolving biomarkers, practical utilization of biomarkers, and updates on biomarkers that are further down the pipeline and may be available for broader use in clinical practice and clinical research. Discuss novel and investigational biomarkers in functional gastrointestinal disorders (disorders of gut-brain interaction) Recognize currently available biomarkers and their potential applications in clinical practice, their strengths, and their limitations. Review the path to biomarker discovery and their role in enhancing patient care, highlighting challenges and future goals.
Presenter
Mayo Clinic College of Medicine
Tracks
Related Products
CANNABIDIOL IS EFFICACIOUS AND SAFE IN ADULT GASTROPARESIS: A RANDOMIZED, PLACEBO-CONTROL TRIAL INCLUDING PHARMACODYNAMICS
BACKGROUND: Idiopathic gastroparesis (IG) is an increasingly prevalent subtype of gastroparesis and causes significant morbidity and decreased quality of life…
THE ROLE OF THE GASTRIC FUNCTION IN FI REGULATION
Food intake and energy expenditure are key regulators of body weight. To regulate food intake, the brain must integrate physiological signals and hedonic cues…
EFFECTS OF THE FGF-19 ANALOG ALDAFERMIN ON BILE ACID SYNTHESIS AND EXCRETION AND BOWEL FUNCTION IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME AND BILE ACID MALABSORPTION: A RANDOMIZED PLACEBO-CONTROL TRIAL
Ageing seems to have a beneficial effect on irritable bowel syndrome (IBS) (Sperber et al. Gastroenterology 2021), and the odds of developing IBS are lower when age is above 50 years (Lovell & Ford CGH 2012). Older age may also affect symptom reporting and quality of life…
PHARMACOGENETIC INTERACTIONS OF MEDICATIONS ADMINSTERED FOR WEIGHT LOSS IN ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
BACKGROUND: Sound evidence support the effectiveness of the transoral outlet reduction (TORe) with full-thickness endoscopic suturing (FTS) or argon plasma coagulation (APC) alone to address post-RYGB weight regain…
